Supplementary Material for: Major Contribution of Genomic Copy Number Variation in Syndromic Congenital Heart Disease: The Use of MLPA as the First Genetic Test
收藏DataCite Commons2020-09-02 更新2024-07-25 收录
下载链接:
https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Major_Contribution_of_Genomic_Copy_Number_Variation_in_Syndromic_Congenital_Heart_Disease_The_Use_of_MLPA_as_the_First_Genetic_Test/5104252/1
下载链接
链接失效反馈官方服务:
资源简介:
Congenital heart disease (CHD) is the most common congenital disorder among live births. When associated with extracardiac abnormalities, it is characterized as a syndromic heart disease (syndromic CHD) and corresponds to 25% of all liveborn infants with a heart defect. The etiology in about 65% of the cases still remains unknown, and in about 35% of the patients, it is associated with genetic factors. In the present study, MLPA and SNP-array techniques were used to investigate a group of 47 patients with syndromic CHD. In total, 16 defects (34%) were identified, of which 12 (25.5%) were classified as pathogenic or probably pathogenic. The most frequent abnormalities were 22q11.2 deletion (22q11.2 deletion syndrome) and 7q11.23 deletion (Williams-Beuren syndrome). We also show that rarer malformations may be associated with syndromic CHD, such as 14q32.33 deletion as well as 17q25.3, 15q11.2 (BP1-BP2), 22q13.31, and 12p13.31 (<i>SLC2A3</i>) duplications. The present study demonstrates that CNVs are important causal factors and should be studied in patients with syndromic CHD. Furthermore, the use of MLPA as a first screening test was appropriate, as this less expensive technology detected 11 of the 12 pathogenic abnormalities (91.6%).
先天性心脏病(Congenital Heart Disease, CHD)是活产婴儿中最常见的先天性病症。当合并心外异常时,该类疾病被归类为综合征性心脏病(syndromic CHD),约占所有存在心脏缺陷的活产婴儿的25%。约65%的病例病因仍未明确,另有约35%的患者发病与遗传因素相关。本研究采用MLPA与SNP-array技术,对47例综合征性CHD患者进行了检测分析。总计检出16处基因缺陷(占比34%),其中12处(占比25.5%)被判定为致病性或疑似致病性变异。最常见的染色体异常为22q11.2缺失(22q11.2缺失综合征)与7q11.23缺失(威廉姆斯-比伦综合征)。本研究还发现,综合征性CHD可与更为罕见的畸形相关,例如14q32.33缺失,以及17q25.3、15q11.2(BP1-BP2区域)、22q13.31与12p13.31区域(<i>SLC2A3</i>基因)的拷贝数重复。本研究证实,拷贝数变异(Copy Number Variations, CNVs)是综合征性CHD的重要致病因素,应对此类患者开展相关检测研究。此外,将MLPA作为首次筛查手段是合理的,这项成本较低的技术成功检出了12处致病性变异中的11处(检出率达91.6%)。
提供机构:
Karger Publishers
创建时间:
2017-06-13



